A new HER2 dual-color, dual-hapten in situ hybridization (Dual ISH) assay is concordant with fluorescence in situ hybridization in gastric carcinoma

被引：0

作者：

McElhinny, A. S. ^{[1
]}

Loftin, I. ^{[1
]}

Miller, R. ^{[1
]}

Roche, Pc ^{[1
]}

Ranger-Moore, J. ^{[1
]}

Grogan, T. ^{[1
]}

Padilla, M. ^{[1
]}

机构：

[1] Ventana Med Syst, Tucson, AZ USA

来源：

HISTOPATHOLOGY | 2010年 / 57卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

291

引用

页码：104 / 104

页数：1

共 50 条

[41] Comparison of fluorescence in situ hybridization and dual color chromogenic in situ hybridization for the assessment of HER2 status on core-needle breast cancer biopsies [J].

Suarez-Gauthier, A. ;

Garcia-Garcia, E. ;

Conde, E. ;

Munoz, A. ;

Torres, M. ;

Miro, C. ;

Garcia-Estevez, L. ;

Lopez-Rios, F. .

CANCER RESEARCH, 2009, 69 (02) :209S-209S

[42] Concordance of HER2 Gene Status between Dual-Color Silver In Situ Hybridization (DSISH) and Fluorescence In Situ Hybridization (FISH) in Invasive Breast Carcinomas (IBCs) after Preoperative Chemotherapy [J].

Kwon, Y. ;

Kang, H. S. ;

Lee, E. S. ;

Park, I. H. ;

Lee, G. K. ;

Park, S. Y. ;

Ro, J. .

MODERN PATHOLOGY, 2013, 26 :51A-51A

[43] Concordance of HER2 Gene Status between Dual-Color Silver In Situ Hybridization (DSISH) and Fluorescence In Situ Hybridization (FISH) in Invasive Breast Carcinomas (IBCs) after Preoperative Chemotherapy [J].

Kwon, Y. ;

Kang, H. S. ;

Lee, E. S. ;

Park, I. H. ;

Lee, G. K. ;

Park, S. Y. ;

Ro, J. .

LABORATORY INVESTIGATION, 2013, 93 :51A-51A

[44] Validation of Dual Color HER2/Chromosome 17 ISH (In-Situ Hybridization) - Comparison with Single Color CISH (Chromogenic In-Situ Hybridization) and Inter-Observer Reproducibility [J].

Branscomb, M. P. ;

Ross, J. R. ;

Horton, D. ;

Rasco, M. S. ;

Winokur, T. S. ;

Reddy, V. V. ;

Wei, S. ;

Harada, S. .

LABORATORY INVESTIGATION, 2013, 93 :490A-490A

[45] Validation of Dual Color HER2/Chromosome 17 ISH (In-Situ Hybridization) - Comparison with Single Color CISH (Chromogenic In-Situ Hybridization) and Inter-Observer Reproducibility [J].

Branscomb, M. P. ;

Ross, J. R. ;

Horton, D. ;

Rasco, M. S. ;

Winokur, T. S. ;

Reddy, V. V. ;

Wei, S. ;

Harada, S. .

MODERN PATHOLOGY, 2013, 26 :490A-490A

[46] Optimal Scoring of Brightfield Dual-Color In Situ Hybridization for Evaluation of HER2 Amplification in Breast Carcinoma How Many Cells Are Enough? [J].

Prendeville, Susan ;

Corrigan, Mark A. ;

Livingstone, Vicki ;

Feeley, Linda ;

Bennett, Michael W. ;

Browne, Tara Jane ;

O'Connell, Fionnuala .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (03) :316-322

[47] Comparison of dual-colour chromogenic in-situ hybridization and fluorescence in-situ hybridization in the assessment of HER2 gene amplification in breast carcinoma [J].

Conlon, Susan ;

Colgan, Aoife ;

Allen, David ;

O'Grady, Anthony ;

Kay, Elaine W. .

HISTOPATHOLOGY, 2011, 58 (02) :320-321

[48] Comparison of Dual-ISH (DISH) With Fluorescence In Situ Hybridization (FISH) and Correlation With Immunohistochemical Findings for HER2/Neu Status in Breast Carcinoma [J].

Layfield, Lester J. ;

Wallander, Michelle L. ;

Tripp, Sheryl R. ;

Redpath, Stella ;

Banks, Peter M. .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (04) :231-236

[49] HER2 status in lung adenocarcinoma: A comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations [J].

Yoshizawa, Akihiko ;

Sumiyoshi, Shinji ;

Sonobe, Makoto ;

Kobayashi, Masashi ;

Uehara, Takeshi ;

Fujimoto, Masakazu ;

Tsuruyama, Tatsuaki ;

Date, Hiroshi ;

Haga, Hironori .

LUNG CANCER, 2014, 85 (03) :373-378

[50] Chromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridization [J].

Cui, J ;

Deubler, DA ;

Rohr, LR ;

Zhu, XL ;

Maxwell, TM ;

Changus, JE ;

Brothman, AR .

CANCER GENETICS AND CYTOGENETICS, 1998, 107 (01) :51-60

← 1 2 3 4 5 →